 UroGens Jelmyto, approved April 2020 for LG-UTUC, has a J code effective 112021 allowing for dramatically more convenient coding reimbursement. Revenues should be about 115,000patient as labelled 6 doses. Jelmytos clinical, quality of life healthcare economic value propositions versus current SOC should keep gross to nets low and allow faster ramp to peak annual sales. 